US WorldMeds logo — company profile

US WorldMeds

Founded 2001 United States Louisville, United States 91 employees Series Unknown Total: $15.00M Health Care, Pharmaceutical

General Information

Company Name US WorldMeds
Founded Year 2001
Location United States Louisville, United States +2
Founders / Decision Makers
Team member
Employees 91
Industries Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when US WorldMeds moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About US WorldMeds

US WorldMeds, a specialty pharmaceutical company, was founded in 2001 with the vision of CEO Paul Breckinridge "Breck" Jones to improve the lives of patients with challenging conditions. The company focuses on developing, licensing, and bringing to market unique healthcare products to address unmet medical needs. With a strong dedication to serving patients, the company works on bringing new therapies and indications across multiple therapeutic areas. US WorldMeds' commitment to improving patients' lives is reflected in its culture, which values honesty, creativity, integrity, passion for success, and stewardship of company resources. The company's last investment was a Venture Round investment in 01 July 2016 led by CRG. The company's headquarters is located in Louisville, Kentucky, with a presence across the U.S. and globally. US WorldMeds offers a fast-paced environment emphasizing innovation and achievement, providing employees with unique opportunities and exciting challenges. For more information about the company's mission and values, visit their website: http://www.usworldmeds.com, or follow them on Twitter at @USWorldMeds.

Taxonomy: pharmaceutical company, healthcare products, specialty pharmaceuticals, global presence, innovation, agility, ethical values, company culture, stewardship, therapeutic areas, CEO leadership, sustainable business

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jul 2016
Grant •••••• 1
Investor
18 Jun 2013
Seed Round •••••• 1
Investor
13 Nov 2006

US WorldMeds Alternatives & Competitors

US WorldMeds vs

Forte Bio-Pharma is a privately held specialty pharmaceutical company focused on in-licensing, devel...

Post Ipo Debt
16 employees
Biotechnology, Health Care
US WorldMeds vs

Keeping vital treatment choices alive for people who need them

Acquired
20 employees
Biotechnology, Health Care
US WorldMeds vs
Athenex
Athenex United States

Athenex is a global specialty oncology pharmaceutical company focused on the development and commerc...

Post Ipo Equity
89 employees
Biotechnology, Pharmaceutical

FAQ About US WorldMeds

US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs. Organized on March 23, 2001 by current CEO Paul Breckinridge "Breck"​ Jones, US...
US WorldMeds was founded in 2001.
US WorldMeds is headquartered in Louisville, United States.
US WorldMeds operates in the following industries: Health Care, Pharmaceutical.
US WorldMeds has approximately 91 employees.
US WorldMeds has completed 3 funding rounds, raising a total of $15.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to US WorldMeds include MediciNova, Inc., Fera Pharmaceuticals, Athenex, Novique Life Sciences Pvt Ltd, Mist Pharmaceuticals, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
US WorldMeds and MediciNova, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors US WorldMeds and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes